Perceptive Advisors LLC Iovance Biotherapeutics, Inc. Transaction History

Perceptive Advisors LLC

$3.83 Billion
Q3 2024

A detailed history of Perceptive Advisors LLC transactions in Iovance Biotherapeutics, Inc. stock. As of the latest transaction made, Perceptive Advisors LLC holds 26,617,709 shares of IOVA stock, worth $217 Million. This represents 6.53% of its overall portfolio holdings.

Number of Shares

26,617,709

Previous 25,933,142 2.64%

Holding current value

$217 Million

Previous $208 Million 20.17%

% of portfolio

6.53%

Previous 6.02%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$7.28 - $11.9 $4.98 Million - $8.15 Million	684,567 Added 2.64%	26,617,709 $250 Million
Q2 2024 Aug 14, 2024	BUY	$7.78 - $14.19 $51.8 Million - $94.5 Million	6,660,151 Added 34.56%	25,933,142 $208 Million
Q1 2024 May 15, 2024	BUY	$7.59 - $17.47 $55.4 Million - $127 Million	7,293,576 Added 60.88%	19,272,991 $286 Million
Q4 2023 Feb 14, 2024	BUY	$3.3 - $8.89 $54,374 - $146,480	16,477 Added 0.14%	11,979,415 $97.4 Million
Q3 2023 Nov 14, 2023	SELL	$4.44 - $8.79 $9.21 Million - $18.2 Million	-2,073,472 Reduced 14.77%	11,962,938 $54.4 Million
Q2 2023 Aug 14, 2023	SELL	$5.36 - $9.06 $6.99 Million - $11.8 Million	-1,303,325 Reduced 8.5%	14,036,410 $98.8 Million
Q1 2023 May 15, 2023	BUY	$5.53 - $8.22 $29.7 Million - $44.1 Million	5,367,955 Added 53.83%	15,339,735 $93.7 Million
Q4 2022 Feb 14, 2023	SELL	$5.62 - $10.0 $1.56 Million - $2.77 Million	-276,844 Reduced 2.7%	9,971,780 $63.7 Million
Q3 2022 Nov 14, 2022	SELL	$9.53 - $13.11 $15 Million - $20.7 Million	-1,577,675 Reduced 13.34%	10,248,624 $98.2 Million
Q2 2022 Aug 15, 2022	SELL	$6.38 - $18.33 $2.39 Million - $6.87 Million	-374,962 Reduced 3.07%	11,826,299 $131 Million
Q1 2022 May 16, 2022	BUY	$12.38 - $19.1 $25.7 Million - $39.6 Million	2,073,320 Added 20.47%	12,201,261 $203 Million
Q4 2021 Feb 14, 2022	SELL	$16.55 - $27.63 $22.5 Million - $37.6 Million	-1,361,831 Reduced 11.85%	10,127,941 $193 Million
Q3 2021 Nov 15, 2021	BUY	$20.35 - $26.63 $10.8 Million - $14.1 Million	530,000 Added 4.84%	11,489,772 $283 Million
Q2 2021 Aug 16, 2021	BUY	$16.33 - $33.07 $37.7 Million - $76.3 Million	2,307,987 Added 26.68%	10,959,772 $285 Million
Q1 2021 May 17, 2021	SELL	$28.67 - $52.59 $14.8 Million - $27.1 Million	-514,519 Reduced 5.61%	8,651,785 $274 Million
Q4 2020 Feb 16, 2021	SELL	$28.04 - $50.26 $25.8 Million - $46.2 Million	-919,328 Reduced 9.12%	9,166,304 $425 Million
Q3 2020 Nov 16, 2020	SELL	$27.75 - $36.3 $47.8 Million - $62.6 Million	-1,723,862 Reduced 14.6%	10,085,632 $332 Million
Q2 2020 Aug 14, 2020	BUY	$27.21 - $41.0 $3.79 Million - $5.72 Million	139,437 Added 1.19%	11,809,494 $324 Million
Q1 2020 May 15, 2020	BUY	$19.54 - $38.85 $44 Million - $87.6 Million	2,253,855 Added 23.94%	11,670,057 $349 Million
Q4 2019 Feb 14, 2020	SELL	$17.95 - $29.41 $28.7 Million - $47 Million	-1,598,500 Reduced 14.51%	9,416,202 $261 Million
Q3 2019 Nov 14, 2019	SELL	$17.99 - $26.0 $16.2 Million - $23.4 Million	-900,425 Reduced 7.56%	11,014,702 $200 Million
Q2 2019 Aug 14, 2019	SELL	$9.78 - $24.52 $3.14 Million - $7.86 Million	-320,684 Reduced 2.62%	11,915,127 $292 Million
Q1 2019 May 15, 2019	SELL	$8.41 - $11.26 $44,573 - $59,678	-5,300 Reduced 0.04%	12,235,811 $116 Million
Q4 2018 Feb 14, 2019	BUY	$7.51 - $11.93 $37.2 Million - $59.1 Million	4,950,912 Added 67.91%	12,241,111 $108 Million
Q3 2018 Nov 14, 2018	BUY	$11.25 - $17.7 $16.2 Million - $25.5 Million	1,437,997 Added 24.57%	7,290,199 $82 Million
Q2 2018 Aug 14, 2018	SELL	$12.45 - $16.95 $3.86 Million - $5.25 Million	-310,000 Reduced 5.03%	5,852,202 $74.9 Million
Q1 2018 May 15, 2018	BUY	$8.1 - $19.5 $11.2 Million - $27 Million	1,386,088 Added 29.02%	6,162,202 $104 Million
Q4 2017 Feb 14, 2018	BUY	$6.65 - $9.25 $332,500 - $462,500	50,000 Added 1.06%	4,776,114 $38.2 Million
Q3 2017 Nov 14, 2017	BUY	$4.45 - $8.55 $21 Million - $40.4 Million	4,726,114	4,726,114 $36.6 Million

Others Institutions Holding IOVA

# of Institutions

313

Shares Held

241M

Call Options Held

3.77M

Put Options Held

1.7M

View Full List

About IOVANCE BIOTHERAPEUTICS, INC.

Ticker IOVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 157,800,992
Market Cap $1.28B
Description
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...

More about IOVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Perceptive Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Perceptive Advisors LLC with notifications on news.

Account

Perceptive Advisors LLC Iovance Biotherapeutics, Inc. Transaction History